Abstract

Drug abuse is prevalent in many sports and at all levels of competition. A sportsman may resort to drug for varying reasons like enhancing performance, to deal with stressful events like injuries, physical pain and to overcome the trauma of retirement. Performance enhancing drugs have its existence since ancient times and have continued to evolve with the improvement and advancements in the drug testing method and scientific researches. Many sports organizations have come to the banning of the intake of performance enhancement drugs. Doping also has innumerable side effects. World Anti-Doping Agency (WADA) maysanction punishment ranging from a reprimand to a life time ban. The duration of ban mayvary on a number of factors like anti-doping violation, circumstances, the substance used andthe repetition of the violation. The current research focuses on the history of doping, theeffects and side effects of different drugs used for doping, and to examine the laws pertaining to doping and drug abuse by sports professionals.

• 1.   Bailey JA, Averbuch RN, Gold MS. Cosmetic psychiatry: from Viagra to MPH. Directions in Psychiatry.2009;29:1–13.
• 2.   Baron DA, Martin DM, Abol Magd S. Doping in sports and its spread to at-risk populations: An International Review. World Psychiatry.2007;6:118–123.
• 3.   Baron DA, Reardon CL, Baron SH. Doping in sport. In: Baron DA, Reardon CL, Baron SH, editors. Clinical Sports Psychiatry: An International Perspective. Oxford, UK: Wiley;2013.
• 4.   Botre F, Pavan A. Enhancement drugs and the athlete. Phys Med Rehabil Clin N Am. 2009; 20:133–148.
• 5.   Catlin DH, Murray TH. Performance-enhancing drugs, fair competition, and Olympic sport. JAMA.1996;276:231–237.
• 6.   Eichner ER. Stimulants in sports. Curr Sports Med Rep.2008; 7:244–245.
• 7.   Elliott S. Erythropoiesis-stimulating agents and other methods to enhance oxygen transport. Br J Pharmacol.2008;154:529–541
• 8.   Franke WW, Berendonk B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic. Clin Chem.1997; 43:1262–1279.
• 9.   Higgins P, Tuttle TD, Higgins CL. Energy beverages: content and safety. Mayo Clin Proc.2010; 85:1033–1041.
• 10.   Holt RI, Sonksen PH. Growth hormone, IGF-I and insulin and their abuse in sport. Br J Pharmacol.2008;154:542–556.
• 11.   International Association of Athletics Federations. IAAF commitment to healthy and drug free athletic,2013. Available from: http://www.iaaf.org/about-iaaf/medical-anti-doping. Accessed August 29,2013.
• 12.   International Olympic Committee. Factsheet: the fight against doping and promotion of athletes’ health,2013. Available from: http://www.olympic.org/Documents/Reference_documents_Factsheets/Fight_against_doping. pdf. Accessed August29,2013.
• 13.   Judkins C, Prock P. Supplements and inadvertent doping – how big is the risk to athletes. Med Sports Sci.2012; 59:143–152.
• 14.   Koshy KM, Griswold E, Schneeberger EE. Interstitial nephritis in a patient taking creatine. N Engl J Med.1999; 340:814–815.
• 15.   Maughan RJ, Shirreffs SM. Nutrition for sports performance: issues and opportunities. Proc Nutr Soc.2012; 71:112–119.
• 16.   McGann B, McGann C. The Story of the Tour de France. Indianapolis, IN, USA: Dog Ear Publishing;2006.
• 17.   Metzl JD, Small E, Levine SR, Gershel JC. Creatine use among young athletes. Pediatrics.2001;108:421–425.
• 18.   Morse ED. Substance use in athletes. In: Baron DA, Reardon CL, Baron SH, editors. Clinical Sports Psychiatry: An International Perspective. Oxford, UK: Wiley;2013
• 19.   Reardon CL, Factor RM. A systematic review of diagnosis and medical treatment of mental illness in athletes. Sports Med.2010; 40:961–980.
• 20.   Riggs P, Levin F,Green AI, et al. Comorbid psychiatric and substance abuse disorders: recent treatment research. Subst Abuse.2008; 29:51–63.
• 21.   Saugy M, Avois L, Saudan C, et al. Cannabis and sport. Br J Sports Med.2006;40 Suppl 1: i13–i15.
• 22.   Schmitt L, Millet G, Robach P, et al. Influence of “living high-training low” on aerobic performance and economy of work in elite athletes. Eur J Appl Physiol.2006; 97:627–636
• 23.   Suedekum NA, Dieff R. Iron and the athlete. Curr Sports Med Rep. 2005; 4:199–202.
• 24.   Teale P, Scarth J, Judson S. Impact of the emergence of designer drugs upon sports doping testing. Bioanalysis.2012;4:71–88.
• 25.   Vardy J, Judge K. Can knowledge protect against acute mountain sickness? J Public Health.2005;27:366–370.
• 26.   Voet W. Breaking the Chain. London, UK: Random House;1999. World An ti-Doping Code, 2015.
• 27.   Wanjek B, Rosendahl J, Strauss B, Gabriel HH. Doping, drugs and drug abuse among adolescents in the State of Thuringia (Germany): prevalence, knowledge and attitudes. Int J Sports Med.2007; 28:346–353.
• 28.   World Anti-Doping Agency. A brief history of anti-doping,2010. Available from: http://www.wada-ama.org/en/about-wada/history/ Accessed August29,2013.
• 29.   Yesalis CE. History of doping in sport. In: Bahrke MS, Yesalis CE, editors. Performance Enhancing Substances in Sport and Exercise. Champaign, IL, USA: Human Kinetics;2002.

Data Sharing Statement

Funding